Premium
Dalbavancin: a new IV antibiotic for skin infections
Author(s) -
Chaplin Steve
Publication year - 2017
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1612
Subject(s) - dalbavancin , medicine , antibiotics , dermatology , microbiology and biotechnology , vancomycin , bacteria , staphylococcus aureus , biology , genetics
Dalbavancin (Xydalba) is a new intravenous antibiotic for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults. This article discusses its properties, efficacy and adverse effects.